Compare Definium Therapeutics Inc. Common Shares (DFTX) vs MiniMed Group Inc. Common Stock (MMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs MiniMed Group Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while MiniMed Group Inc. Common Stock trades at $19.55 (market cap $5.38B). The key difference: Definium Therapeutics Inc. Common Shares and MiniMed Group Inc. Common Stock are close in size by market cap, and MiniMed Group Inc. Common Stock is more actively traded (9,619,294 versus 1,966,636). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| DFTX | MMED | |
|---|---|---|
Market Cap | $4.71B | $5.38B |
Volume | 1,966,636 | 9,619,294 |
Sector | Health | Health |
52-Week High | $48.45 | $23.84 |
52-Week Low | $10.68 | $10.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $5.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About MiniMed Group Inc. Common Stock
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →
